Latest news

Clinical

J&J Reports Positive Phase 2/3 Results for Imaavy in Warm Autoimmune Hemolytic Anemia

Johnson & Johnson has reported results from the pivotal phase 2/3 Energy study evaluating Imaavy in patients with warm...
Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D of the Phase 2 CIRRUS-HCM trial evaluating EDG-7500 in patients...
Research & Development

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

The Advanced Research Projects Agency for Health (ARPA-H) has announced a new round of funding through its THRIVE program,...
Clinical

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Bausch + Lomb has decided to discontinue development of its investigational glaucoma eye drop BL1107 after the treatment failed...
Uncategorized

Xiaflex Meets Phase 3 Endpoints in Plantar Fibromatosis Study

Keenova Therapeutics reported positive phase 3 results for Xiaflex...
Commercial

Leo Cancer Care Raises $65 Million Series D Round to Expand Upright Radiotherapy Platform

Medical technology company Leo Cancer Care has closed a...
Insights

The Rise of AI-Native Biotech Companies

Executive Summary Artificial intelligence is reshaping nearly every aspect of the life sciences industry. Most pharmaceutical and biotechnology companies are integrating...
Insights

Why Every Pharma Company Is Becoming a Technology Company

Executive Summary For much of its history, the pharmaceutical industry has been defined by scientific discovery. Competitive advantage depended on breakthrough...
Commercial

Novartis Set to Buy UK Biotech Myricx For Over $1.1B

Novartis is expanding its presence in the antibody-drug conjugate (ADC) field by agreeing to acquire Myricx Bio in a...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...
Regulatory

FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

The U.S. Food and Drug Administration (FDA) has expanded...
Commercial

In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

Vertex Pharmaceuticals is making its biggest-ever acquisition to date, to the tune of $10 billion, of Crinetics Pharmaceuticals. While...
Clinical

Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

Bristol Myers Squibb has disclosed detailed results from the phase 3 KRYSTAL-10 trial evaluating Krazati (adagrasib) in combination with...
Clinical

Kailera and Hengrui Report Phase 3 Results for Oral GLP-1 Drug in Obesity and Type 2 Diabetes

Kailera Therapeutics and its partner Jiangsu Hengrui Pharmaceutical reported that the oral GLP-1 receptor agonist HRS-7535 met the primary...
Commercial

Moderna sets its sight on the UK for new Innovation and Technology Center

The American pharmaceutical heavyweight has unveiled its plans to...
Commercial

Seyltx Secures Option to License GluN2B Antagonists from NeurOp

Seyltx, a clinical-stage biotherapeutics company based in Cambridge, Massachusetts,...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Research & Development

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

The Advanced Research Projects Agency for Health (ARPA-H) has...
Clinical

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Bausch + Lomb has decided to discontinue development of...
Insights

Top 10 Barriers to Scaling Genomics Programs in Healthcare

Executive Summary Genomics is rapidly becoming a cornerstone of modern...

Research & Development

Market Access

Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...
Manufacturing

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival